|
Rise
of the Nordic warriors
The Baltic Sea Region (BSR), an investment network and a consortium
of six countries, namely, Denmark, Estonia, Finland, Latvia,
Lithuania and Sweden, is trying to attract Indian investment
in industries like pharmaceuticals and information technology.
Nandini Patwardhan reports
Glenmark
splits business into specialty and generics
Glenmark Pharmaceuticals announced plans to roll its generics
business into a new subsidiary and list it through an IPO
by middle of next year.
Destination
Finland
On the basis of international comparisons completed in recent
years, Finland has been consistently ranked as one of the
best places to do business in the world. Here is a snapshot
of the country, which is trying to attract Indian investment
in the knowledge-driven sectors like pharmaceuticals and IT
Sweden:
A European leader in life sciences
Sweden's pharma and biotech industry offers a wide range of
investment opportunities, including in-licensing, collaboration
and direct investment. Firms cover the entire value chain,
with particular strengths in drug discovery and development,
medical engineering and biopharmaceutical production
Latvia
and India: Building strong ties
Latvia is looking at attracting Indian investment, much like
the other member countries of Baltic Sea Region
Destination
Lithuania
Lithuania, one of the relatively peaceful countries in the
EU, is looking at Indian investment in the country to start
and increase in the coming years. Lithuanian Development Agency
presents a snapshot of Lithuania
Biocon
and Abraxis announce approval of Abraxane in India
Biocon and Abraxis BioScience, an integrated global biopharmaceutical
company, have announced the approval by the country's Drug
Controller General to market Abraxane for injectable suspension
(paclitaxel protein-bound particles) in India for the treatment
of breast cancer.
Biogen
Idec opens first office in India
Biogen Idec has officially opened an office in Gurgaon. Dr
Gunther Winkler, Senior Vice-President, Strategic Initiatives,
attended the event as part of his visit to India.
Suven
secures three Indian product patents
Suven Life Sciences has announced that the Indian Patent Office
has granted three product patents 208688, 208714 and 209540
corresponding to three New Chemical Entities (NCEs) for the
treatment of disorders associated with neuro-degenerative
diseases and these patents are valid until 2022.
Ajanta
Pharma enters ENT and Pediatrics
Ajanta Pharma, a specialty focused company, has entered the
niche segment of ENT and paediatrics through a new dedicated
division named Aureus, meaning 'gold' in Greek.
Wockhardt
acquires Morton Grove in the US
Wockhardt has announced the acquisition of Morton Grove Pharmaceuticals,
a liquid generic and speciality dermatology company in the
US having sales revenue of US$ 52 million.
Dabur
Pharma signs agreement with Combino Pharm
Dabur Pharma has announced that it has signed a supply and
distribution agreement with Combino Pharm, one of Spain's
leading generic companies, to distribute and market generic
oncology products in the Spanish market.
Generex
gets ok to sell its insulin spray
Generex Biotechnology has announced that Generex Oral-lyn,
its proprietary oral insulin spray product, has been approved
for importation and commercial marketing and sale in India
for the treatment of diabetes by the Central Drugs Standard
Control Organization (CDSCO), Directorate General of Health
Services, Government of India.
VLife
hives off research division as NovaLead Pharma
The Pune-based drug discovery software company, VLife Sciences,
has hived off its research division into a separate entity,
named as NovaLead Pharma.
Ipca
launches new pain manager
Ipca Laboratories has just launched India's first Etodolac,
called Etova, which is a new generation pain manager that
is considerably safer than Coxibs, which have been linked
to cardiovascular side-effects.
Accutest
Lab expands Ahmedabad clinical research operations
Accutest Research Laboratories, a full service clinical research
organisation with core strengths in bioequivalence/bioavailability
and pharmacokinetic studies and formulation development, inaugurated
its second facility, a clinical trial laboratory at Ahmedabad,
with an investment of Rs 7 crore.
Events
CII
Life Sciences Conclave
"The Indian government is willing to partner with the
Indian industry for a new bio-technology strategy and will
announce a policy within the next two weeks," said Kapil
Sibal, Honourable Union Minister for Science and Technology
and Earth Sciences, Government of India, at the valedictory
session of the 'Life Science Conclave-2007', organised by
the Confederation of Indian Industry (CII).
Arogya
2007: Promoting traditional medicines
In an effort to give a contemporary perspective to the centuries
old therapeutic heritage of India, the Indian Trade Promotion
Organisation (ITPO), in association with Department of AYUSH
(ayurveda, yoga and naturopathy, unani, siddha and homeopathy),
Ministry of Health and Family Welfare, Government of India
got together and organised Arogya 2007.
India
Workshop 2007
The India Workshop 2007 on 'Primary packaging and drug delivery
trends for injectables' was held in October. The workshop
was sponsored by Nuova Ompi from the Stevanato Group, Ypsomed,
and West Pharmaceuticals.
Symposium
on stem cells
On the second anniversary of its founding, Nichi-in Centre
for Regenerative Medicine (NCRM) held its second symposium
on regenerative medicine with the topic of presentation being
stem cell research and its clinical studies.
Analytica
Ancon India 2007 scores well in all disciplines
Analytica Anacon India 2007 closed its gates in Hyderabad
on November 2 with some outstanding results: More than 3,000
decision-makers and users, especially from Indian laboratories,
came to the two halls at the modern Hitex Center to gather
information about the latest equipment, applications and products
in the sectors for instrumental analysis, laboratory technology
and biotechnology.
Indian
pharma industry a continuing success story
A new breed of companies from the emerging markets is catching
their Western counterparts off guard. At the Pharma Summit
2007, Dr Swati Piramal, Director-Strategic Alliances and Communications,
Nicholas Piramal India, remarked that Asian history is the
history of globalisation.
'Focus
on the 'clever' parts of outsourcing'
Peter Berweger, European Chair of KPMG's Pharma & Chemicals
Practice spoke to Viveka Roychowdhury on the sidelines of
the recent CII Pharma Summit. Excerpts from the interview
…
|
